ISCD Learning
October 2023 - Pediatric Bone Densitometry Course
Includes Multiple Live Events. The next is on 10/28/2023 at 10:00 AM (EDT)
-
Register
- Non-Member - $200
- Full Member - $100
- MOC Only - $200
- Community Member - $200
- Professional Member - $200
Course Date
October 28, 2023
Course Description
The Pediatric Bone Densitometry Course provides the most current research and best-practice techniques for obtaining and interpreting bone mineral density (BMD) measurements in children and adolescents. This educational program is designed to improve learner competence in the area of pediatric densitometry. Learners will have the opportunity to take the knowledge gained from this educational program and properly/consistently apply it to their professional practices.
Target Audience
The content is designed for healthcare providers with an interest in skeletal health assessment, including specialists, generalists and technologists working in family medicine, general and internal medicine, endocrinology, rheumatology, obstetrics/gynecology, radiology, pediatrics, physical and occupational therapy, nuclear medicine and research.
Learning Objectives
After attending the course, participants should be better prepared to:
1. Identify the most appropriate and reproducible sites for densitometry in children and adolescents.
2. Outline the corrections in DXA measurements that should be made when acquiring assessments in children and adolescents.
3. Describe the uses of measurement tools for acquiring bone densitometry assessments including DXA, as well as those other than DXA.
4. Summarize the elements that should be included in a DXA report for a child or adolescent.
5. Recognize issues that arise in children with chronic disease(s) that many times arise in the skeletal assessment.
Method of Participation
This activity will be offered through Zoom, allowing the learner to watch and ask questions in a live format on October 28, 2023. At the end of the activity, learners will be asked to evaluate the activity online and then claim credit and print certificates. Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.
Rates
Cancellation Policy
Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
ACCME Accreditation Statement:
The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.
AMA PRA Category 1 Credit(s)™
It is anticipated that this learning activity will be approved for a maximum 4 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.
ASRT Credit Designation:
It is anticipated that this activity will be approved for 4.50 Category A continuing education credits.
Deadline to Claim Credit:
Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.
Dr. Neil Jacob Paloian
Assistant Professor (CHS), Department of Pediatrics, Division of Nephrology
University of Wisconsin School of Medicine and Public Health
Neil Paloian, MD is Associate Professor of Pediatrics at the University of Wisconsin School of Medicine and Public Health division of Nephrology. He is the director of the multi-disciplinary Pediatric Bone and Mineral Metabolism Clinic at the UW American Familiy Children’s Hospital. Dr Paloian specializes in the evaluation and treatment of children with acquired or inherited bone disorders such as pediatric osteoporosis, osteogenesis imperfecta, X-linked hypophosphatemic rickets, and hypophosphatasia. Dr Paloian also directs the Pediatric Kidney Stone clinic at UW. His research focuses on better understanding disorders of mineral disease in children, including both bone mineralization and renal calcifications.
Disclosures: Fees for Non-CME Services: Ultragenyx
Dr. Nina Ma, MD, CCD
Associate Professor of Pediatrics
University of Colorado School of Medicine
Nina Ma, MD CCD is Associate Professor of Pediatrics at the University of Colorado School of Medicine. She is the Director and Founder of the Bone and Mineral Metabolism Program and holds the Kerr Family Endowed Chair in Endocrinology at Children’s Hospital Colorado. Early-on in her career, Dr. Ma established an interest in pediatric disorders of bone and mineral metabolism. Her current areas of clinical focus and research are in rare disorders, such as multicentric carpotarsal osteolysis, autosomal dominant hypoparathyroidism and X-linked hypophosphatemic rickets.
Disclosures: Contracted Research: Ascendis Pharma, Ultragenyx, Calcilytix Royalty: UpToDate, Current Osteoporosis Reports.
Course Planning Committee
Tamara Vokes, MD, CCD No Financial Relationships to Disclose
Brad Richmond, MD, FACR,CCD No Financial Relationships to Disclose
John Schouseboe, MD, PhD, CCD No Financial Relationships to Disclose
Harold Rosen, MD, CCD No Financial Relationships to Disclose
Edwin Oei, MD, PhD No Financial Relationships to Disclose
Course Content Reviewers
Campbell Macgregor, CCD No Financial Relationships to Disclose
Kelly Molinar-Kagan, RT(R)(M) CBDT No Financial Relationships to Disclose
Monique Carroll, RT, CBDT No Financial Relationships to Disclose
Merle Wigeson, MD No Financial Relationships to Disclose
October 2023 Course Faculty
Neil Jacob Paloian, MD Disclosures: Fees for Non-CME Services received directly from Commercial Interest or agent * (e.g., Speakers’ Bureaus)
Nina Ma, MD, CCD Disclosures: Contracted Research: Ascendis Pharma, Ultragenyx, Calcilytix Royalty: UpToDate, Current Osteoporosis Reports
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendance Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
